Commonwealth Retirement Investments’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.37M Buy
72,135
+4,253
+6% +$248K 1.35% 21
2025
Q4
$3.66M Buy
67,882
+1,922
+3% +$92.5K 1.18% 26
2025
Q3
$2.97M Buy
65,960
+6,777
+11% +$317K 1.01% 34
2025
Q2
$2.74M Buy
59,183
+11,690
+25% +$574K 1.04% 31
2025
Q1
$2.9M Buy
47,493
+973
+2% +$56.7K 1.18% 25
2024
Q4
$2.63M Buy
46,520
+1,033
+2% +$57.7K 1.08% 28
2024
Q3
$2.35M Buy
45,487
+3,541
+8% +$166K 0.99% 33
2024
Q2
$1.74M Buy
+41,946
New +$1.88M 0.8% 42

Other funds holding BMY

Commonwealth Retirement Investments's BMY Position: Q1 2026 in Review

Commonwealth Retirement Investments increased its Bristol-Myers Squibb (BMY) stake by 6.3% in Q1 2026, buying an estimated $248K and bringing the position to 72,135 shares worth $4.37M. The position accounts for 1.35% of the portfolio, ranked #21.

Commonwealth Retirement Investments first reported a position in BMY in Q2 2024 and has held it in 8 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Commonwealth Retirement Investments held 72,135 shares of Bristol-Myers Squibb worth $4.37M as of Q1 2026.
  • Commonwealth Retirement Investments bought 4,253 Bristol-Myers Squibb shares in Q1 2026, an estimated $248K.
  • Bristol-Myers Squibb made up 1.35% of Commonwealth Retirement Investments's portfolio in Q1 2026, its #21 holding.
  • Commonwealth Retirement Investments first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 8 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Commonwealth Retirement Investments's 13F filing for Q1 2026, filed 11 May 2026.